Literature DB >> 18480460

R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switch.

Silvana Tasca1, Siu-Hong Ho, Cecilia Cheng-Mayer.   

Abstract

To examine the pathway of the coreceptor switching of CCR5-using (R5) virus to CXCR4-using (X4) virus in simian-human immunodeficiency virus SHIV(SF162P3N)-infected rhesus macaque BR24, analysis was performed on variants present at 20 weeks postinfection, the time when the signature gp120 V3 loop sequence of the X4 switch variant was first detected by PCR. Unexpectedly, circulating and tissue variants with His/Ile instead of the signature X4 V3 His/Arg insertions predominated at this time point. Phylogenetic analysis of the sequences of the C2 conserved region to the V5 variable loop of the envelope (Env) protein showed that viruses bearing HI insertions represented evolutionary intermediates between the parental SHIV(SF162P3N) and the final X4 HR switch variant. Functional analyses demonstrated that the HI variants were phenotypic intermediates as well, capable of using both CCR5 and CXCR4 for entry. However, the R5X4 intermediate virus entered CCR5-expressing target cells less efficiently than the parental R5 strain and was more sensitive to both CCR5 and CXCR4 inhibitors than either the parental R5 or the final X4 virus. It was also more sensitive than the parental R5 virus to antibody neutralization, especially to agents directed against the CD4 binding site, but not as sensitive as the late X4 virus. Significantly, the V3 loop sequence that determined CXCR4 use also conferred soluble CD4 neutralization sensitivity. Collectively, the data illustrate that, similar to human immunodeficiency virus type 1 (HIV-1) infection in individuals, the evolution from CCR5 to CXCR4 usage in BR24 transitions through an intermediate phase with reduced virus entry and coreceptor usage efficiencies. The data further support a model linking an open envelope gp120 conformation, better CD4 binding, and expansion to CXCR4 usage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480460      PMCID: PMC2446975          DOI: 10.1128/JVI.00570-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  76 in total

1.  Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.

Authors:  C Pastore; R Nedellec; A Ramos; S Pontow; L Ratner; D E Mosier
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Gene splicing and mutagenesis by PCR-driven overlap extension.

Authors:  Karin L Heckman; Larry R Pease
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Conserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switching.

Authors:  Cristina Pastore; Rebecca Nedellec; Alejandra Ramos; Oliver Hartley; John L Miamidian; Jacqueline D Reeves; Donald E Mosier
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

4.  HIV-1 coreceptor use in triple-class treatment-experienced patients: baseline prevalence, correlates, and relationship to enfuvirtide response.

Authors:  Tom Melby; Michael Despirito; Ralph Demasi; Gabrielle Heilek-Snyder; Michael L Greenberg; Neil Graham
Journal:  J Infect Dis       Date:  2006-06-02       Impact factor: 5.226

5.  HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Authors:  Timothy J Wilkin; Zhaohui Su; Daniel R Kuritzkes; Michael Hughes; Charles Flexner; Robert Gross; Eoin Coakley; Wayne Greaves; Catherine Godfrey; Paul R Skolnik; Joseph Timpone; Benigno Rodriguez; Roy M Gulick
Journal:  Clin Infect Dis       Date:  2007-01-17       Impact factor: 9.079

6.  Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.

Authors:  Pirada Suphaphiphat; Max Essex; Tun-Hou Lee
Journal:  Virology       Date:  2006-11-13       Impact factor: 3.616

7.  Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.

Authors:  Evelien M Bunnik; Esther D Quakkelaar; Ad C van Nuenen; Brigitte Boeser-Nunnink; Hanneke Schuitemaker
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaques.

Authors:  Siu-hong Ho; Silvana Tasca; Lili Shek; Amy Li; Agegnehu Gettie; James Blanchard; Daniel Boden; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

9.  Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.

Authors:  Wei Huang; Susan H Eshleman; Jonathan Toma; Signe Fransen; Eric Stawiski; Ellen E Paxinos; Jeannette M Whitcomb; Alicia M Young; Deborah Donnell; Francis Mmiro; Philippa Musoke; Laura A Guay; J Brooks Jackson; Neil T Parkin; Christos J Petropoulos
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

10.  Structural definition of a conserved neutralization epitope on HIV-1 gp120.

Authors:  Tongqing Zhou; Ling Xu; Barna Dey; Ann J Hessell; Donald Van Ryk; Shi-Hua Xiang; Xinzhen Yang; Mei-Yun Zhang; Michael B Zwick; James Arthos; Dennis R Burton; Dimiter S Dimitrov; Joseph Sodroski; Richard Wyatt; Gary J Nabel; Peter D Kwong
Journal:  Nature       Date:  2007-02-15       Impact factor: 49.962

View more
  23 in total

1.  Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.

Authors:  Rajeev Gautam; Yoshiaki Nishimura; Wendy R Lee; Olivia Donau; Alicia Buckler-White; Masashi Shingai; Reza Sadjadpour; Stephen D Schmidt; Celia C LaBranche; Brandon F Keele; David Montefiori; John R Mascola; Malcolm A Martin
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.

Authors:  Madina Shakirzyanova; Lily Tsai; Wuze Ren; Agegneu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.

Authors:  Yoshiaki Nishimura; Masashi Shingai; Ronald Willey; Reza Sadjadpour; Wendy R Lee; Charles R Brown; Jason M Brenchley; Alicia Buckler-White; Rahel Petros; Michael Eckhaus; Victoria Hoffman; Tatsuhiko Igarashi; Malcolm A Martin
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Effect of B-cell depletion on coreceptor switching in R5 simian-human immunodeficiency virus infection of rhesus macaques.

Authors:  Silvana Tasca; Ke Zhuang; Agegnehu Gettie; Heather Knight; James Blanchard; Susan Westmoreland; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

5.  Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4.

Authors:  Gregory Q Del Prete; Beth Haggarty; George J Leslie; Andrea P O Jordan; Josephine Romano; Nathaniel Wang; Jianbin Wang; Michael C Holmes; David C Montefiori; James A Hoxie
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

6.  Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth L McMonagle; Ayman Samman; Margaret J Hosie
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

7.  Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.

Authors:  Wuze Ren; Silvana Tasca; Ke Zhuang; Agegnehu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

8.  Identification of dual-tropic HIV-1 using evolved neural networks.

Authors:  Gary B Fogel; Susanna L Lamers; Enoch S Liu; Marco Salemi; Michael S McGrath
Journal:  Biosystems       Date:  2015-09-28       Impact factor: 1.973

Review 9.  How HIV changes its tropism: evolution and adaptation?

Authors:  Donald E Mosier
Journal:  Curr Opin HIV AIDS       Date:  2009-03       Impact factor: 4.283

10.  Understanding the HIV coreceptor switch from a dynamical perspective.

Authors:  Christel Kamp
Journal:  BMC Evol Biol       Date:  2009-11-30       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.